HealthMore in Health→
Ultra-low dosing could widen access to expensive cancer care
A report from STAT says ultra-low doses may help costly cancer treatments reach more patients in poorer countries, putting affordability at the center of oncology access.
Key Takeaways
- STAT reports that ultra-low doses could expand access to costly cancer treatments.
- The access implications are especially significant for poorer countries.
DE
DT Editorial Team··via statnews.com